Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...

Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed ...

An HIV positive TB patient, holds a packet of tablets received as part of his treatment at Rutsanana Polyclinic in Glen Norah township, Harare June 24, 2019. - (Photo by Jekesai NJIKIZANA / AFP) ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

This is a prospective observational study that will enroll individuals with suspected pulmonary TB and follow those with culture-confirmed, rifamycin-sensitive TB for 18 months, from the initiation of ...

More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...

An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...

A tuberculosis outbreak in Edmonton’s inner-city has prompted a renewed look at how the airborne disease spreads and how it is treated. Primary Care Alberta and the Edmonton Zone Medical Officers of ...